Prostate cancer Board decisions

The Board denied service connection for prostate cancer and hypothyroidism, finding no evidence of in-service disease or injury, lack of exposure to herbicides during service, and insufficient medical evidence linking the conditions to service.

The Board has granted a 40 percent rating for prostate cancer with voiding dysfunction, effective December 1, 2020. The decision is based on the Veteran's reported symptoms and the VA examination findings.

Service connection for diabetes mellitus and prostate cancer is granted on a presumptive basis due to herbicide exposure. The claims of service connection for other conditions are remanded.

The Board has dismissed the Veteran's claims for service connection for heart disease, prostate cancer, and diabetes mellitus as secondary to herbicide exposure due to his death.

The Veteran's claim for special monthly pension based on the need for regular aid and attendance is remanded due to a duty-to-assist error.

The Veteran's claims for increased ratings and SMC were denied, while the claim for compensation under 38 U.S.C. § 1151 for sleep apnea was also denied.

The Veteran was granted a 60 percent rating for his prostate cancer residuals and related bladder disorder, effective December 19, 2018. The decision also granted Dependents' Educational Assistance (DEA) benefits effective the same date.

The Veteran's appeals for effective dates and ratings related to PTSD, prostate cancer residuals, and bilateral hearing loss have been dismissed. The appeal for a TDIU has been granted, as well as basic eligibility for Dependents' Educational Assistance.

The Veteran's claim for an earlier effective date for the grant of service connection for prostate cancer residuals is dismissed as it attempts to reopen a final rating decision, which is not allowed.

The Veteran's prostate cancer and type 2 diabetes are granted as secondary to in-service exposure to herbicide agents, including Agent Orange.

The Board has granted service connection for prostate cancer, finding that the Veteran's in-service asbestos exposure is at least as likely as not related to his current condition.

The Veteran's claim for a higher disability rating for other specified trauma and stressor related disorder was denied. The effective date of TDIU was granted from December 16, 2013, based on the service-connected disabilities. Basic eligibility for Dependents' Educational Assistance (DEA) was also granted from December 16, 2013.

The Board has remanded the Veteran's claims for service connection for asthma, hypertension, and prostate cancer due to alleged exposure to herbicide agents during service. The claims are being remanded for further development including verification of exposure and a VA examination.

The Veteran's prostate cancer is found to be related to his exposure to toxic substances in service, specifically ionizing radiation and organophosphate agents and pesticides. Service connection for prostate cancer is granted.

The Board has granted the Veteran's claims for service connection for Parkinson's disease and prostate cancer, finding that his exposure to herbicide agents during service in Thailand is presumed. The conditions are considered presumptive due to their association with herbicide agent exposure.

The Veteran's TDIU and DEA benefits are granted with an effective date of November 1, 2019. The Board found the Veteran was unable to engage in substantially gainful employment due to his service-connected disabilities as of this date.

The Board has remanded the cases due to a pre-decisional duty to assist error regarding obtaining outstanding medical records.

The Board has remanded the claims for hypertension, GERD, and residuals of prostate cancer due to a lack of formal findings regarding the Veteran's exposure to herbicide agents or napalm. The claims are being returned for further development.

The Veteran's appeal is dismissed due to his death. The Board has no jurisdiction to adjudicate the merits of this case.

The Board denied service connection for coronary artery disease and prostate cancer, finding that the conditions were not incurred during active military service.